Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

TerminatedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Breast Cancer
Interventions
PROCEDURE

Tumor Sample

Tumor sample submission can consist of a fresh frozen tissue sample or a formalin-fixed paraffin embedded tissue block.

PROCEDURE

Serum Sample

Serum is to be collected prior to the initiation of lonafarnib treatment and 28 days after the last dose of lonafarnib.

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Indiana University School of Medicine

OTHER

collaborator

Emory University

OTHER

lead

Hoosier Cancer Research Network

OTHER